Influence of an SGLT2 inhibitor, tofogliflozin, on the resting heart rate in relation to adipose tissue insulin resistance

AIMS: To examine the effects of a sodium–glucose co‐transporter 2 (SGLT2) inhibitor, tofogliflozin, on resting heart rate by exploring baseline factors that independently influenced changes in the resting heart rate. METHODS: Data on 419 participants in tofogliflozin phase 2/3 trials were analysed....

Full description

Saved in:
Bibliographic Details
Published in:Diabet Med
Main Authors: Nojima, T., Matsubayashi, Y., Yoshida, A., Suganami, H., Abe, T., Ishizawa, M., Fujihara, K., Tanaka, S., Kaku, K., Sone, H.
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2020
Subjects:
Research Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7496771/
https://ncbi.nlm.nih.gov/pubmed/32096571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dme.14279
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items